Locations:
SearchPlease join our staff as we participate or present in the following oral and poster presentations at the 2017 ASTRO Annual Meeting
CNS ePoster Discussion 1 – Brain Metastases
Hall A-B1, Ground Level
1:15PM
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
ePoster
Shireen Parsai, MD
Optimizing Intracranial Disease Control for Breast Cancer Patients with HER2 Positive Brain Metastasis: Combining SRS and CNS-Penetrating HER2 Blockade Therapy
Poster Viewing Q&A 1: GU, Biology
Hall A-B1, Ground Level
1:15PM
Poster Q&A
Jay Ciezki, MD
The Effect of Androgen Deprivation Therapy on Prostate Cancer-Specific Mortality in Patients with High-Risk Prostate Cancer Treated with I-125 Brachytherapy as the Sole Radiation Therapeutic Modality
Poster Q&A
The Effect of Prostatectomy Technique on Genitourinary Toxicity
Poster Q&A
Omar Mian, MD
Molecular Profiling of Small Cell Bladder Cancer Reveals Gene Expression Determinants of an Aggressive Phenotype
Poster Q&A
Mohamed Abazeed, MD
Divison of Labor and Plasticity in a Phenotypically Diverse Intratumoral Ecosystem Promotes Therapeutic Resistance in Small Cell Lung Carcinoma
Poster Viewing Q&A 2: Nonmalignant, Palliative, Patient Reported Outcomes, Patient Safety, Informatics
Hall A-B1, Ground Level
4:45PM
Poster Q&A
Amr Essa, MD
Intracoronary Brachytherapy in the Era of Drug-Eluting Stents
Poster Q&A
Charles Leyrer, MD
Long-Term Follow-Up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients with Stage I Peripheral Non-Small Cell Lung Cancer
Poster Q&A
Martin Tom, MD
Outcomes Following Spine Stereotactic Radiosurgery for the Treatment of Melanoma Spine Metastases
Lung 1 – SBRT
Room 8
4:45PM
Oral
Gregory Videtic, MD
Long-Term Follow-Up on NRG Oncology RTOG 0915 (NCCTG N0927): A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients with Stage I Peripheral Non-Small Cell Lung Cancer
Advertisement
Oral
Gregory Videtic, MD
An Association Between Increasingly Abnormal Pretreatment Diffusion Capacity in Medically Inoperable Early Stage Lung Cancer Patients and Increasing Local Failure after Stereotactic Body Radiation Therapy
Advertisement
Advertisement
First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses
Global R&D efforts expanding first-line and relapse therapy options for patients
Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels
A case study on the value of access to novel therapies through clinical trials
Findings highlight an association between obesity and an increased incidence of moderate-severe disease
Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access 23456
Key learnings from DESTINY trials
Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients